Ruminococcus gnavus: friend or foe for human health

EH Crost, E Coletto, A Bell… - FEMS Microbiology …, 2023 - academic.oup.com
Ruminococcus gnavus was first identified in 1974 as a strict anaerobe in the gut of healthy
individuals, and for several decades, its study has been limited to specific enzymes or …

[HTML][HTML] Pathobionts in inflammatory bowel disease: origins, underlying mechanisms, and implications for clinical care

A Gilliland, JJ Chan, TJ De Wolfe, H Yang, BA Vallance - Gastroenterology, 2024 - Elsevier
The gut microbiota plays a significant role in the pathogenesis of both forms of inflammatory
bowel disease (IBD), namely Crohn's disease (CD) and ulcerative colitis (UC). While …

[HTML][HTML] Butyrate's role in human health and the current progress towards its clinical application to treat gastrointestinal disease

K Hodgkinson, F El Abbar, P Dobranowski… - Clinical Nutrition, 2023 - Elsevier
Butyrate is a key energy source for colonocytes and is produced by the gut microbiota
through fermentation of dietary fiber. Butyrate is a histone deacetylase inhibitor and also …

Drivers and determinants of strain dynamics following fecal microbiota transplantation

TSB Schmidt, SS Li, OM Maistrenko, W Akanni… - Nature medicine, 2022 - nature.com
Fecal microbiota transplantation (FMT) is a therapeutic intervention for inflammatory
diseases of the gastrointestinal tract, but its clinical mode of action and subsequent …

The human gut microbiome: from association to modulation

TSB Schmidt, J Raes, P Bork - Cell, 2018 - cell.com
Our understanding of the human gut microbiome continues to evolve at a rapid pace, but
practical application of thisknowledge is still in its infancy. This review discusses the type of …

[HTML][HTML] Colonization of the live biotherapeutic product VE303 and modulation of the microbiota and metabolites in healthy volunteers

M Dsouza, R Menon, E Crossette, SK Bhattarai… - Cell Host & Microbe, 2022 - cell.com
Manipulation of the gut microbiota via fecal microbiota transplantation (FMT) has shown
clinical promise in diseases such as recurrent Clostridioides difficile infection (rCDI) …

A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients

AB Hall, M Yassour, J Sauk, A Garner, X Jiang… - Genome medicine, 2017 - Springer
Background Inflammatory bowel disease (IBD) is characterized by chronic inflammation of
the gastrointestinal tract that is associated with changes in the gut microbiome. Here, we …

MUC2 and related bacterial factors: therapeutic targets for ulcerative colitis

D Yao, W Dai, M Dong, C Dai, S Wu - EBioMedicine, 2021 - thelancet.com
Abstract The mucin2 (MUC2) mucus barrier acts as the first barrier that prevents direct
contact between intestinal bacteria and colonic epithelial cells. Bacterial factors related to …

Specific bacteria and metabolites associated with response to fecal microbiota transplantation in patients with ulcerative colitis

S Paramsothy, S Nielsen, MA Kamm, NP Deshpande… - Gastroenterology, 2019 - Elsevier
Background & Aims Fecal microbiota transplantation (FMT) can induce remission in patients
with ulcerative colitis (UC). In a randomized controlled trial of FMT in patients with active UC …

The super-donor phenomenon in fecal microbiota transplantation

BC Wilson, T Vatanen, WS Cutfield… - Frontiers in cellular and …, 2019 - frontiersin.org
Fecal microbiota transplantation (FMT) has become a highly effective bacteriotherapy for
recurrent Clostridium difficile infection. Meanwhile the efficacy of FMT for treating chronic …